Enhanced Proinflammatory State and Autoimmune Activation: a Breakthrough to Understanding Chronic Diseases


Onat A., Can G.

CURRENT PHARMACEUTICAL DESIGN, vol.20, no.4, pp.575-584, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 4
  • Publication Date: 2014
  • Doi Number: 10.2174/138161282004140213145551
  • Title of Journal : CURRENT PHARMACEUTICAL DESIGN
  • Page Numbers: pp.575-584

Abstract

Insight is provided herein into the novel mechanisms of cardiometabolic risk. Previous reports, including the epidemiological work of the Turkish Adult Risk Factor study, indicated that proinflammatory state and oxidative stress are crucial for evaluating cardiometabolic risk. Autoimmune pathways in the course of oxidative stress are major determinants of cardiorenal and metabolic risk. The latter encompasses metabolic syndrome, type 2 diabetes, coronary heart disease, and chronic kidney disease (CKD).